It is time to stop ignoring malignancy in heart transplantation: A call to arms

Journal of Heart and Lung Transplantation

Volumn 24, Issue 8, 2005, Pages 1111-1113

  Hauptman, Paul J ^a,c   Mehra, Mandeep R ^b  

^a SAINT LOUIS UNIVERSITY   (United States)

^b OCHSNER CLINIC FOUNDATION   (United States)

^c SAINT LOUIS UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SCREENING; CARDIAC ALLOGRAFT VASCULOPATHY; CAUSE OF DEATH; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; FOLLOW UP; HEART PROTECTION; HEART TRANSPLANTATION; HUMAN; MALIGNANT TRANSFORMATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCREENING TEST;

EID: 23744454727     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2004.06.009     Document Type: Editorial

References (25)

1. I. Penn, T.E. Starzl A summary of the status of de novo cancer in transplant recipients Transplant Proc 4 1972 719 732
2. R.J. Rodeheffer, D.C. Naftel, L.W. Stevenson Secular trends in cardiac transplant recipient and donor management in the United States, 1990 to 1994. A multi-institutional study Circulation 94 1996 2883 2889
3. P.J. Hauptman, A.I. Kartashov, G.S. Couper Changing patterns in donor and recipient risk a ten-year evolution in one heart transplant center J Heart Lung Transplant 14 1995 654 658
4. J.D. Hosenpud, L.E. Bennett, B.M. Keck, M.M. Boucek, R.J. Novick The Registry of the International Society for Heart and Lung Transplantation eighteenth official report-2001 J Heart Lung Transplant 20 2001 805 815
5. H.A. Valantine Cardiac allograft vasculopathy after heart transplantation risk factors and management May J Heart Lung Transplant 23 5 Suppl 2004 S187 S193
6. J.G. Thomson Production of severe athero in a transplanted human heart Lancet 2 1969 1088 1092
7. D.H. Liang, S.Z. Gao, J. Botas Prediction of angiographic disease by intracoronary ultrasonographic findings in heart transplant recipients J Heart Lung Transplant 15 1996 980 987
8. M.R. Mehra, H.O. Ventura, R. Chambers Predictive model to assess risk for cardiac allograft vasculopathy an intravascular ultrasound study JAMA 26 1995 1537 1544
9. J.K. Kirklin, D.C. Naftel, R.C. Bourge Evolving trends in risk profiles and causes of death after heart transplantation a ten-year multi-institutional study J Thor Cardiovasc Surg 125 2003 881 890
10. J.K. Kobashigawa, J.M. Tobis, R.C. Starling Multicenter intravascular ultrasound validation study among heart transplant recipients outcomes after five years (abstract) J Heart Lung Transplant 23 2004 S51
11. D.O. Taylor, L.B. Edwards, P.J. Mohacsi The Registry of the International Society for Heart and Lung Transplantation twentieth official adult heart transplant report-2003 J Heart Lung Transplant 22 2003 616 624
12. L.J. Swinnen, M.R. Costanzo-Nordin, S.G. Fisher Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients N Engl J Med 323 1990 1723 1728
13. G. Huebner, M. Karthaus, K. Pethig, M. Freund, A. Ganser Myelodysplastic syndrome and acute myelogenous leukemia secondary to heart transplantation Transplantation 70 2000 688 690
14. J. O'Neill, L.B. Edwards, D.O. Taylor Mycophenolate mofetil and the risk of developing malignancy following orthotopic heart transplantation (abstract) J Heart Lung Transplant 23 2004 S110
15. M.M. Mita, A. Mita, E.K. Rowinsky The molecular target of rapamycin as a therapeutic target in cancer Cancer Biol Ther 2 2003 S169 S177
16. G.E. Koehl, J. Andrassy, M. Guba Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice Transplantation 77 2004 1319 1326
17. M.R. Mehra, J. Kobashigawa, S. Hunt Molecular testing and prediction of clinical outcome in heart transplantation a prospective multicenter trial (abstract) J Heart Lung Transplant 23 2004 S106
18. B. Czarnik, D. Yip, P.J. Hauptman Management of long-term heart transplant survivors with very low cyclosporin levels a safe approach? Circulation 104 2001 646 647
19. D.A. Baran, L. Segura, S. Kushwaha Tacrolimus monotherapy in adult cardiac transplant recipients intermediate-term results J Heart Lung Transplant 20 2001 59 70
20. E. Loh, F.J. Couch, C. Hendricksen Development of donor-derived prostate cancer in a recipient following orthotopic heart transplantation JAMA 277 1997 133 137
21. J.F. Buell, J. Trofe, M.J. Hanaway Transmission of donor cancer into cardiothoracic transplant recipients Surgery 130 2001 660 666
22. J.A. Kobashigawa, S. Katznelson, H. Laks Effect of pravastatin on outcomes after cardiac transplantation N Engl J Med 333 1995 621 627
23. K. Wenke, B. Meiser, J. Thiery Simvastatin reduces graft vessel disease and mortality after heart transplantation a four-year randomized trial Circulation 96 1997 1398 1402
24. H.J. Eisen, E.M. Tuzcu, R. Dorent Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients N Engl J Med 349 2003 847 858
25. D. Mancini, S. Pinney, D. Burkhoff Use of rapamycin slows progression of cardiac transplantation vasculopathy Circulation 108 2003 48 53